Pioneers in transformative research with clinical applications will discuss how space is advancing discoveries within the biomedical community at the...

OKLAHOMA CITY, OKLA. – With a $1.2 million grant to the University of Oklahoma, an OU Health urologic oncologist is...

Reston, VA—Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an effective and well-tolerated treatment for metastatic...

Pancreatic cancer, recognized as one of the deadliest cancers, poses a persistent challenge for medical professionals globally due to its...

A group of researchers at University of California San Diego has identified the cause of a “short-circuit” in cellular pathways,...

Immunotherapy is based on harnessing a person’s own immune system to attack cancer cells. However, patients with certain tumors do...

The length of telomeres that protect the ends of our chromosomes should be tightly regulated. Those that are too long...

NRG Oncology recently reported the results  from the radiotherapy randomization, which was the second step of their NRG-RTOG 0848 clinical...

“ due to the general lack of robust predictive biomarkers, a standardized risk stratification tool is not utilized in clinical...

UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic...